NCT05315895 (DACOS) is a clinical trial of natural aging process in Chronic Disease, sponsored by Guangzhou University of Traditional Chinese Medicine.

Who is sponsoring NCT05315895?

NCT05315895 is sponsored by Guangzhou University of Traditional Chinese Medicine.

What drugs are being tested in NCT05315895?

Interventions in NCT05315895: natural aging process.

What condition does NCT05315895 study?

NCT05315895 studies Chronic Disease, Cancer, Dementia Alzheimers, Metabolic Disease, Aging, Alzheimer Disease, Early Onset.

Is NCT05315895 still recruiting?

NCT05315895 is currently recruiting now. Last updated 15 November 2022.

Last reviewed 2022-11-15 · How we verify

NCT05315895: DACOS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Dampness Syndrome of Chinese Medicine Cohort Study

Recruiting now Last updated 15 November 2022

What this trial tests

trial testing natural aging process in Chronic Disease in 100,000 participants. Currently enrolling.

Timeline

6 June 2022

Primary endpoint
30 December 2027

30 March 2028

Quick facts

Lead sponsor	Guangzhou University of Traditional Chinese Medicine
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100,000
Start date	6 June 2022
Primary completion	30 December 2027
Estimated completion	30 March 2028
Sites	1 location across China

Drugs / interventions tested

natural aging process

Conditions studied

Chronic Disease — all drugs for Chronic Disease →
Cancer — all drugs for Cancer →
Dementia Alzheimers — all drugs for Dementia Alzheimers →
Metabolic Disease — all drugs for Metabolic Disease →

Sponsor

Guangzhou University of Traditional Chinese Medicine

Who can join

Adults 35 to 79, any sex, with Chronic Disease or Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The researchers plain to build a large-scale, longitudinal, prospective cohort characterized by TCM dampness syndrome. With the biobank of this cohort the investigators want to find the causality between TCM dampness syndrome and clinical chronic diseases and a new way to treat clinical disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Health-related quality of life in populations with diabetes, prediabetes, and normal glycemic levels in Guangzhou, China: a cross-sectional study.
Li M, Liu N, Jiang G, Zeng H, et al · · 2025 · PMID 40487765 · DOI 10.3389/fendo.2025.1518204

Verify or expand the search:

Other recruiting trials for Chronic Disease

Currently open trials in the same condition.

NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
NCT07375550 — Determinants of Medication Non-Adherence Among Patients With Chronic Diseases in Egyptian Community Pharmacies · recruiting
NCT07120464 — Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations · recruiting

Other Guangzhou University of Traditional Chinese Medicine trials

Trials by the same sponsor.

NCT07348965 — Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis · NA · recruiting
NCT07121088 — Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Compar · Phase 4 · not yet recruiting
NCT07104422 — An Epidemiological and Long-Term Endpoint Registry Study on Disease-Syndrome Correlation Patterns in Comorbid Population · not yet recruiting
NCT07088523 — Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Effica · Phase 4 · not yet recruiting
NCT07120724 — Real-World Study on Chinese Medicine for Treating Chikungunya Fever · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05315895 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Guangzhou University of Traditional Chinese Medicine
Last refreshed: 15 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05315895.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing